Breaking News Alert

Click here if this e-mail doesn't display properly The NSABB explains its recommendations for influenza papers The US National Science Advisory Board for Biosecurity (NSABB) today outlines, for the first time, the rationale behind its request for two H5N1 influenza papers to be published in a redacted form. As well as publishing the full statement, Nature also releases a related Q&A with the acting chair of the NSABB. Access the Comment article and the Q&A online.     Facebook    Google+     Twitter     LinkedIn    Digg    StumbleUpon     As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Hong Kong | Madrid | Melbourne | Munich | Paris | San Francisco | Seoul | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.